Skip to content

On-Pump vs. Off-Pump CABG in High-Risk Patients (EuroSCORE 6+)

Aortocoronary Bypasses in High-Risk Patients (EuroSCORE 6+) With or Without Use of the Cardio-Pulmonary Bypass.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00606372
Acronym
PRAGUE 6+
Enrollment
220
Registered
2008-02-04
Start date
2006-06-30
Completion date
2009-12-31
Last updated
2008-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Heart Disease, Post-Operative Complications

Keywords

Off-pump, OPCAB, EuroSCORE, high-risk patients, Quality of life, Validity of EuroSCORE

Brief summary

Previous studies comparing on-pump and off-pump operating strategy did only partially demonstrate benefits of the off-pump myocardial revascularisation.In primary end-points (MI, death, renal failure, and so on) there was no significant difference, but in secondary end-points we observed benefits resulting for patients. We would like to show the benefit of the method without extracorporeal circulation in patients with higher and hight operation risk, coming from EuroSCORE classification system (6 points and more).

Interventions

PROCEDUREOPCAB - the off-pump coronary artery bypass

surgical myocardial revascularisation without use of cardio-pulmonary bypass, using stabilising devices on beating heart

Sponsors

Charles University, Czech Republic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* stable form of ischemic heart disease * unstable angina pectoris * acute myocardial infarction * additive EuroSCORE 6 and more * informed approval of the patient

Exclusion criteria

* significant heart valve disease, requesting surgery * aortic aneurysm requesting surgery

Design outcomes

Primary

MeasureTime frame
death, heart stroke, brain stroke, renal failure, early reoperation30 days
heart stroke, brain stroke, death, renal failure, early reoperation30 days and 365 days

Secondary

MeasureTime frame
length of in-hospital stay, blood losses, number of blood-transfusion, new appeared atrial fibrillation, 1-year mortality, quality of life-angina classified by CCS in 1-year follow up, length of mechanical ventilation30 days and 365 days

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026